FDA Had A Public Discussion Regarding Drug Compounders

January 8, 2013

The Food and Drug Administration had a public discussion with public health officials from 50 states on how best to strengthen regulation of compounding pharmacies. This comes after a multi-state outbreak of fungal meningitis due to contaminated steroid injections from a compounding pharmacy.

comments powered by Disqus